Personalis, Inc.

Healthcare

NASDAQ:PSNL · NASDAQ Global Market

Market Cap $898.70M Beta 2.28 P/E (TTM) -11.0

$10.54 +3.44%

+$0.34 today

52W Low $3.84High $12.53

Vol 3.31M · Avg 2.31M

EPS (TTM) -$0.92Medical - Diagnostics & Research

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+69.73%

Period High

$12.10

Period Low

$4.41

Latest

$10.54

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Butterfly Network, Inc.

NYSE:BFLY

$1.90B

Tyra Biosciences, Inc.

NASDAQ:TYRA

$1.68B

CareDx, Inc

NASDAQ:CDNA

$1.26B

Geron Corporation

NASDAQ:GERN

$817.94M

Maravai LifeSciences Holdings, Inc.

NASDAQ:MRVI

$732.01M

Castle Biosciences, Inc.

NASDAQ:CSTL

$620.70M

Fulgent Genetics, Inc.

NASDAQ:FLGT

$512.08M

Evolent Health, Inc.

NYSE:EVH

$503.35M

Rezolute, Inc.

NASDAQ:RZLT

$490.13M

Myriad Genetics, Inc.

NASDAQ:MYGN

$421.24M

What is the latest PSNL filing?

The latest filing shown is 4/A dated Jun 11, 2026.

How many recent filings does PSNL have?

Intrinsic Alpha currently shows 20 recent filings for PSNL.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.